---
input_text: A Surge of DNA Damage Links Transcriptional Reprogramming and Hematopoietic
  Deficit in Fanconi Anemia. Impaired DNA crosslink repair leads to Fanconi anemia
  (FA), characterized by a unique manifestation of bone marrow failure and pancytopenia
  among diseases caused by DNA damage response defects. As a germline disorder, why
  the hematopoietic hierarchy is specifically affected is not fully understood. We
  find that reprogramming transcription during hematopoietic differentiation results
  in an overload of genotoxic stress, which causes aborted differentiation and depletion
  of FA mutant progenitor cells. DNA damage onset most likely arises from formaldehyde,
  an obligate by-product of oxidative protein demethylation during transcription regulation.
  Our results demonstrate that rapid and extensive transcription reprogramming associated
  with hematopoietic differentiation poses a major threat to genome stability and
  cell viability in the absence of the FA pathway. The connection between differentiation
  and DNA damage accumulation reveals a novel mechanism of genome scarring and is
  critical to exploring therapies to counteract the aplastic anemia for the treatment
  of FA patients.
raw_completion_output: |-
  primary_disease: Fanconi anemia
  medical_actions: exploring therapies to counteract the aplastic anemia
  symptoms: bone marrow failure; pancytopenia; aborted differentiation; depletion of FA mutant progenitor cells; genotoxic stress; DNA damage accumulation
  chemicals: formaldehyde
  action_annotation_relationships: exploring therapies to counteract the aplastic anemia TREATS bone marrow failure IN Fanconi anemia; exploring therapies to counteract the aplastic anemia TREATS pancytopenia IN Fanconi anemia; exploring therapies to counteract the aplastic anemia TREATS aborted differentiation IN Fanconi anemia; exploring therapies to counteract the aplastic anemia TREATS depletion of FA mutant progenitor cells IN Fanconi anemia; exploring therapies to counteract the aplastic anemia TREATS genotoxic stress IN Fanconi anemia; exploring therapies to counteract the aplastic anemia TREATS DNA damage accumulation IN Fanconi anemia
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  exploring therapies to counteract the aplastic anemia TREATS DNA damage accumulation IN Fanconi anemia

  ===

extracted_object:
  primary_disease: MONDO:0019391
  medical_actions:
    - exploring therapies to counteract the aplastic anemia
  symptoms:
    - HP:0005528
    - HP:0001876
    - aborted differentiation
    - depletion of FA mutant progenitor cells
    - genotoxic stress
    - DNA damage accumulation
  chemicals:
    - CHEBI:16842
  action_annotation_relationships:
    - subject: exploring therapies
      predicate: TREATS
      object: HP:0005528
      qualifier: MONDO:0019391
      subject_qualifier: to counteract the aplastic anemia
    - subject: exploring therapies to counteract the aplastic anemia
      predicate: TREATS
      object: HP:0001876
      qualifier: MONDO:0019391
    - subject: exploring
      predicate: TREATS
      object: aborted differentiation
      qualifier: MONDO:0019391
      subject_qualifier: 'NULL'
      object_qualifier: 'NULL'
      subject_extension: therapies to counteract the aplastic anemia
      object_extension: 'NULL'
    - subject: exploring therapies to counteract the aplastic anemia
      predicate: TREATS
      object: depletion of FA mutant progenitor cells
      qualifier: MONDO:0019391
    - subject: <exploring therapies>
      predicate: <TREATS>
      object: <genotoxic stress>
      qualifier: <Fanconi anemia>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <therapies>
      object_extension: <>
    - subject: exploring therapies to counteract the aplastic anemia
      predicate: TREATS
      object: DNA damage accumulation
      qualifier: MONDO:0019391
      subject_extension: therapies to counteract the aplastic anemia
      object_extension: DNA damage accumulation
named_entities:
  - id: MONDO:0019391
    label: Fanconi anemia
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation (HSCT)
  - id: CHEBI:18198
    label: ADCs
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: MAXO:0000750
    label: conditioning regimens
  - id: CHEBI:37153
    label: Calcineurin inhibitor
  - id: CHEBI:38215
    label: Calcium channel blocker
  - id: CHEBI:4031
    label: Cyclosporine
  - id: CHEBI:8069
    label: Phenobarbital
  - id: CHEBI:2668
    label: Amlodipine
  - id: MAXO:0000149
    label: Hematopoietic cell transplantation (HCT)
  - id: MAXO:0000016
    label: Cellular therapy
  - id: HP:0001871
    label: Blood dyscrasias
  - id: MAXO:0000595
    label: Radiography
  - id: HP:0005528
    label: Bone marrow failure
  - id: HP:0034057
    label: Congenital defects
  - id: CHEBI:28901
    label: Busulfan
  - id: CHEBI:44185
    label: Methotrexate
  - id: MONDO:0005233
    label: Non-small cell lung cancer (NSCLC)
  - id: CHEBI:33364
    label: Platinum
  - id: MAXO:0000647
    label: chemotherapy
  - id: HP:0030358
    label: Non-small cell lung cancer
  - id: MAXO:0001479
    label: Allogeneic hematopoietic stem cell transplantation (allo-HSCT)
  - id: HP:0002863
    label: Myelodysplasia
  - id: HP:0001909
    label: Leukemia
  - id: MONDO:0016624
    label: Hereditary anemia
  - id: MAXO:0001001
    label: Gene therapy
  - id: MONDO:0005570
    label: Hematological disorders
  - id: HP:0002664
    label: cancer
  - id: MONDO:0015253
    label: Diamond Blackfan anemia
  - id: MAXO:0000600
    label: Kidney replacement therapy (KRT)
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0003259
    label: Elevated serum creatinine (SCr > 100micromol/l)
  - id: MONDO:0001529
    label: Bone marrow failure (BMF)
  - id: HP:0002860
    label: oral squamous cell carcinoma (SCC)
  - id: MONDO:0100339
    label: Fanconi anemia (FA)
  - id: CHEBI:28680
    label: Ara-C
  - id: CHEBI:27899
    label: Cisplatin
  - id: HP:0011793
    label: Malignant tumors
  - id: HP:0000818
    label: Endocrinopathies
  - id: HP:0002745
    label: Oral leukoplakia
  - id: CHEBI:64357
    label: rituximab
  - id: CHEBI:61049
    label: Tacrolimus
  - id: HP:0002910
    label: elevated liver function tests
  - id: CHEBI:125354
    label: plerixafor
  - id: CHEBI:231614
    label: Nivolumab
  - id: CHEBI:25016
    label: PBS
  - id: MONDO:0009693
    label: Multiple Myeloma
  - id: CHEBI:28876
    label: Melphalan
  - id: CHEBI:229764
    label: Selinexor
  - id: CHEBI:229762
    label: Eltanexor
  - id: HP:0006775
    label: Multiple Myeloma
  - id: CHEBI:229763
    label: exportin 1 inhibitors
  - id: MONDO:0015909
    label: aplastic anemia
  - id: HP:0004808
    label: Acute myeloid leukaemia
  - id: MAXO:0000004
    label: Surgery
  - id: MAXO:0000014
    label: Radiotherapy
  - id: MONDO:0001881
    label: Septic shock
  - id: MAXO:0001021
    label: Antimicrobial treatment
  - id: MAXO:0000174
    label: Antifungal treatment
  - id: HP:0001876
    label: Pancytopenia
  - id: HP:0001945
    label: Fever
  - id: CHEBI:133748
    label: Citrate
  - id: CHEBI:41879
    label: Dexamethasone
  - id: CHEBI:33281
    label: Antimicrobial
  - id: CHEBI:35718
    label: Antifungal
  - id: MONDO:0044033
    label: Posterior reversible encephalopathy syndrome (PRES)
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: MAXO:0001188
    label: Laparoscopy
  - id: HP:0000988
    label: Skin rash
  - id: MONDO:0010161
    label: Tyrosinemia Type 1
  - id: HP:0001919
    label: acute kidney injury (AKI)
  - id: HP:0000822
    label: hypertension
  - id: MAXO:0001298
    label: therapy
  - id: HP:0040012
    label: Increased chromosomal breakage
  - id: MONDO:0004631
    label: Tongue cancer (TC)
  - id: CHEBI:4735
    label: EDTA
  - id: HP:0002014
    label: Diarrhea
  - id: HP:0025085
    label: Blood in stool
  - id: HP:0000568
    label: Microphthalmia
  - id: HP:0000482
    label: microcornea
  - id: HP:0000508
    label: ptosis
  - id: HP:0011496
    label: limbal neovascularization
  - id: HP:0001097
    label: keratoconjunctivitis sicca
  - id: CHEBI:62932
    label: Mycophenolate
  - id: MONDO:0008903
    label: Lung Cancer
  - id: MONDO:0100096
    label: COVID-19
  - id: HP:0032169
    label: severe infections
  - id: MONDO:0044348
    label: Hemoglobinopathies
  - id: MONDO:0005109
    label: HIV
  - id: HP:0001622
    label: Preterm delivery
  - id: HP:0100601
    label: Eclampsia
  - id: MONDO:0043455
    label: Hereditary hematological malignancy (HHM)
  - id: MONDO:0043797
    label: Spinal Cord Injury (SCI)
  - id: CHEBI:27306
    label: Vitamin B6
  - id: HP:0001915
    label: aplastic anemia
  - id: MONDO:0001056
    label: Gastric cancer
  - id: MAXO:0001193
    label: Esophagogastroduodenoscopy
  - id: CHEBI:31941
    label: Oxaliplatin
  - id: HP:0012126
    label: Gastric cancer
  - id: MONDO:0005575
    label: Colorectal Cancer
  - id: CHEBI:46345
    label: 5-fluorouracil (5-FU)
  - id: CHEBI:15640
    label: Folinic acid
  - id: HP:0008209
    label: Premature ovarian insufficiency (POI)
  - id: HP:0000026
    label: Testicular failure
  - id: CHEBI:81569
    label: Follicle-stimulating hormone (FSH)
  - id: CHEBI:74539
    label: Luteinizing hormone (LH)
  - id: MONDO:0010651
    label: myelodysplastic syndromes (MDS)
  - id: MAXO:0000079
    label: genetic counseling
  - id: MONDO:0018881
    label: myelodysplastic syndromes
  - id: MAXO:0010033
    label: cord blood transplantation
  - id: CHEBI:50443
    label: hematopoietic stem cells (HSC)
  - id: MONDO:0000159
    label: Bone marrow failure syndromes
  - id: HP:0001903
    label: Anemia
  - id: MONDO:0007959
    label: Medulloblastoma (MB)
  - id: HP:0002885
    label: Medulloblastoma
  - id: CHEBI:3498
    label: CTX
  - id: HP:0000815
    label: Hypergonadotropic hypogonadism
  - id: HP:0000044
    label: Hypogonadotropic hypogonadism
  - id: HP:0008223
    label: Subclinical hypothyroidism
  - id: HP:0011787
    label: Central hypothyroidism
  - id: HP:0000855
    label: Insulin resistance
  - id: HP:0003119
    label: Dyslipidemia
  - id: HP:0002671
    label: Basal cell cancer
  - id: CHEBI:7421
    label: N-acetylcysteine (NAC)
  - id: CHEBI:66919
    label: ruxolitinib
  - id: MAXO:0000757
    label: infusion
  - id: CHEBI:35341
    label: steroids
  - id: MONDO:0011996
    label: Chronic Myeloid Leukemia (CML)
  - id: MAXO:0009004
    label: Whole exome sequencing
  - id: CHEBI:83766
    label: Olaparib
  - id: CHEBI:38637
    label: Tyrosine Kinase Inhibitors (TKIs)
  - id: HP:0002488
    label: Acute leukemia
  - id: CHEBI:6801
    label: Metformin
  - id: CHEBI:7864
    label: Oxymetholone
  - id: CHEBI:16842
    label: formaldehyde
